Product Information
Name:FX 2149
Brand:Targetmol
Description:FX 2149 is a GTP-binding inhibitor that potently inhibits LRRK2 GTP binding and kinase activity in vitro and attenuates the toxic effects of LRRK2 in Parkinson’s disease models.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:319.38
Formula:C15H17N3O3S
Purity:99.94%
Technical inquiry about: FX 2149
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.